Valuation (28%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 11.54 | -17.63 |
PEG Ratio (TTM) | 0.98 | -5.55 |
P/S Ratio (TTM) | N/A | 39.15 |
P/B Ratio (TTM) | -6.88 | 5.84 |
P/FCF Ratio (TTM) | -119.24 | -147.41 |
Price to 5YR AVG Earnings Ratio | N/A | -34.54 |
Price to 5YR AVG FCF Ratio | N/A | -1.05 |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | 3.73% | 289.89% |
ROE (TTM) | 5.25% | -4,257.84% |
Net Profit Margin (TTM) | N/A | -1,047.58% |
ROIC 5YR AVG | N/A | -16.45% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 14.72% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -18.23% | N/A | N/A |
Cash Flow | -29.46% | N/A | N/A |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.09 | 4.95 |
Quick Ratio (TTM) | 0.09 | 4.93 |
D/E Ratio (TTM) | -0.34 | 1.30 |
Interest Coverage (TTM) | N/A | -11.54 |
Piotroski F-Score | 2 | 3 |
Altman Z-Score | 13.48 | 21.08 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 896.36% |